These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 1490888)
41. Thiocoraline, a new depsipeptide with antitumor activity produced by a marine Micromonospora. I. Taxonomy, fermentation, isolation, and biological activities. Romero F; Espliego F; Pérez Baz J; García de Quesada T; Grávalos D; de la Calle F; Fernández-Puentes JL J Antibiot (Tokyo); 1997 Sep; 50(9):734-7. PubMed ID: 9360617 [TBL] [Abstract][Full Text] [Related]
42. Antibacterial and antitumor macrolides from Streptomyces sp. Is9131. Zhao PJ; Fan LM; Li GH; Zhu N; Shen YM Arch Pharm Res; 2005 Nov; 28(11):1228-32. PubMed ID: 16350846 [TBL] [Abstract][Full Text] [Related]
43. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. Ueda H; Nakajima H; Hori Y; Fujita T; Nishimura M; Goto T; Okuhara M J Antibiot (Tokyo); 1994 Mar; 47(3):301-10. PubMed ID: 7513682 [TBL] [Abstract][Full Text] [Related]
44. NK154183A and B, antitumor substances produced by Streptomyces sp. Tsuchiya K; Kimura C; Nishikawa K; Harada T; Nishikiori T; Tatsuta K J Antibiot (Tokyo); 1996 Dec; 49(12):1281-3. PubMed ID: 9031676 [No Abstract] [Full Text] [Related]
46. Structurally diverse metabolites from the rare actinobacterium Saccharothrix xinjiangensis. Babadi ZK; Sudarman E; Ebrahimipour GH; Primahana G; Stadler M; Wink J J Antibiot (Tokyo); 2020 Jan; 73(1):48-55. PubMed ID: 31451754 [TBL] [Abstract][Full Text] [Related]
47. Two new lankacidin-related metabolites from Streptomyces sp. HS-NF-1178. Lu C; Li JM; Qi H; Zhang H; Zhang J; Xiang WS; Wang JD; Wang XJ J Antibiot (Tokyo); 2018 Mar; 71(3):397-401. PubMed ID: 29348529 [TBL] [Abstract][Full Text] [Related]
48. Isolation of a new phenazine antibiotic, DOB-41, from Pseudomonas species. Shoji J; Sakazaki R; Nakai H; Terui Y; Hattori T; Shiratori O; Kondo E; Konishi T J Antibiot (Tokyo); 1988 May; 41(5):589-94. PubMed ID: 3384746 [TBL] [Abstract][Full Text] [Related]
49. [Cytotoxic and antibacterial substances from the ascidian Aplidium antillense]. Benslimane AF; Pouchus YF; Le Boterff J; Verbist JF; Roussakis C; Monniot F J Nat Prod; 1988; 51(3):582-3. PubMed ID: 3404153 [No Abstract] [Full Text] [Related]
50. Calicheamicins, a novel family of antitumor antibiotics: taxonomy, fermentation and biological properties. Maiese WM; Lechevalier MP; Lechevalier HA; Korshalla J; Kuck N; Fantini A; Wildey MJ; Thomas J; Greenstein M J Antibiot (Tokyo); 1989 Apr; 42(4):558-63. PubMed ID: 2722671 [TBL] [Abstract][Full Text] [Related]
51. Production and isolation of two novel esperamicins in a chemically defined medium. Lam KS; Veitch JA; Golik J; Rose WC; Doyle TW; Forenza S J Antibiot (Tokyo); 1995 Dec; 48(12):1497-501. PubMed ID: 8557609 [No Abstract] [Full Text] [Related]
52. Bioactive metabolites from the Arctic fungus Yu HB; Jiao H; Zhu YP; Zhang JP; Lu XL; Liu XY J Asian Nat Prod Res; 2019 Oct; 21(10):961-969. PubMed ID: 29911892 [TBL] [Abstract][Full Text] [Related]
53. Isolation and characterization of atramycin A and atramycin B, new isotetracenone type antitumor antibiotics. Fujioka K; Furihata K; Shimazu A; Hayakawa Y; Seto H J Antibiot (Tokyo); 1991 Sep; 44(9):1025-8. PubMed ID: 1938611 [No Abstract] [Full Text] [Related]
54. Macquarimicins, microbial metabolites from Micromonospora. I. Discovery, taxonomy, fermentation and biological properties. Jackson M; Karwowski JP; Theriault RJ; Rasmussen RR; Hensey DM; Humphrey PE; Swanson SJ; Barlow GJ; Premachandran U; McAlpine JB J Antibiot (Tokyo); 1995 Jun; 48(6):462-6. PubMed ID: 7622430 [TBL] [Abstract][Full Text] [Related]
55. A new antibiotic, cypemycin. Taxonomy, fermentation, isolation and biological characteristics. Komiyama K; Otoguro K; Segawa T; Shiomi K; Yang H; Takahashi Y; Hayashi M; Otani T; Omura S J Antibiot (Tokyo); 1993 Nov; 46(11):1666-71. PubMed ID: 7802859 [TBL] [Abstract][Full Text] [Related]
56. Pyrindamycins A and B, new antitumor antibiotics. Ohba K; Watabe H; Sasaki T; Takeuchi Y; Kodama Y; Nakazawa T; Yamamoto H; Shomura T; Sezaki M; Kondo S J Antibiot (Tokyo); 1988 Oct; 41(10):1515-9. PubMed ID: 3192502 [No Abstract] [Full Text] [Related]
57. Porothramycin, a new antibiotic of the anthramycin group: production, isolation, structure and biological activity. Tsunakawa M; Kamei H; Konishi M; Miyaki T; Oki T; Kawaguchi H J Antibiot (Tokyo); 1988 Oct; 41(10):1366-73. PubMed ID: 3192492 [TBL] [Abstract][Full Text] [Related]
58. Novonestmycins A and B, two new 32-membered bioactive macrolides from Streptomyces phytohabitans HBERC-20821. Wan Z; Fang W; Shi L; Wang K; Zhang Y; Zhang Z; Wu Z; Yang Z; Gu Y J Antibiot (Tokyo); 2015 Mar; 68(3):185-90. PubMed ID: 25204346 [TBL] [Abstract][Full Text] [Related]
59. Retymicin, galtamycin B, saquayamycin Z and ribofuranosyllumichrome, novel secondary metabolites from Micromonospora sp. Tü 6368. I. Taxonomy, fermentation, isolation and biological activities. Antal N; Fiedler HP; Stackebrandt E; Beil W; Ströch K; Zeeck A J Antibiot (Tokyo); 2005 Feb; 58(2):95-102. PubMed ID: 15835721 [TBL] [Abstract][Full Text] [Related]
60. Verucopeptin, a new antitumor antibiotic active against B16 melanoma. I. Taxonomy, production, isolation, physico-chemical properties and biological activity. Nishiyama Y; Sugawara K; Tomita K; Yamamoto H; Kamei H; Oki T J Antibiot (Tokyo); 1993 Jun; 46(6):921-7. PubMed ID: 8344873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]